Matrix metalloproteinases at cancer tumor-host interface - PubMed (original) (raw)

Review

Matrix metalloproteinases at cancer tumor-host interface

Agnès Noël et al. Semin Cell Dev Biol. 2008 Feb.

Free article

Abstract

The increasing diversity in both substrates and functions of matrix metalloproteinases (MMPs) makes these enzymes central regulators in the complex tumor ecosystem composed of cancer cells and their microenvironment. In the majority of cancers, membrane-associated and extracellular proteases are mainly produced by host cells including inflammatory cells, endothelial cells, pericytes and fibroblasts. Recent data based on in vitro and in vivo studies have demonstrated the relevance of these enzymes in multiple processes controlling cancer growth, angiogenesis and metastatic dissemination. This review will present the emerging MMP-related features of cancer cells and host cells.

PubMed Disclaimer

Similar articles

• Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression.
  Jodele S, Blavier L, Yoon JM, DeClerck YA. Jodele S, et al. Cancer Metastasis Rev. 2006 Mar;25(1):35-43. doi: 10.1007/s10555-006-7887-8. Cancer Metastasis Rev. 2006. PMID: 16680570 Review.
• [Roles of serine proteases and matrix metalloproteinases in tumor invasion and angiogenesis].
  Masson V. Masson V. Bull Mem Acad R Med Belg. 2006;161(5):320-6. Bull Mem Acad R Med Belg. 2006. PMID: 17283905 French.
• [Breast cancer invasion: the key role of normal cells of host tissues].
  Foidart JM, Polette M, Birembaut P, Noel A. Foidart JM, et al. Bull Acad Natl Med. 1994 Mar;178(3):533-42; discussion 542-4. Bull Acad Natl Med. 1994. PMID: 8076190 Review. French.
• Matrix metalloproteinases and cancer.
  Cox G, O'Byrne KJ. Cox G, et al. Anticancer Res. 2001 Nov-Dec;21(6B):4207-19. Anticancer Res. 2001. PMID: 11908674 Review.
• Tumour invasion and matrix metalloproteinases.
  Polette M, Nawrocki-Raby B, Gilles C, Clavel C, Birembaut P. Polette M, et al. Crit Rev Oncol Hematol. 2004 Mar;49(3):179-86. doi: 10.1016/j.critrevonc.2003.10.008. Crit Rev Oncol Hematol. 2004. PMID: 15036258 Review.

Cited by

• PAK1 as a therapeutic target.
  Kichina JV, Goc A, Al-Husein B, Somanath PR, Kandel ES. Kichina JV, et al. Expert Opin Ther Targets. 2010 Jul;14(7):703-25. doi: 10.1517/14728222.2010.492779. Expert Opin Ther Targets. 2010. PMID: 20507214 Free PMC article. Review.
• Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?
  Rivera S, Khrestchatisky M, Kaczmarek L, Rosenberg GA, Jaworski DM. Rivera S, et al. J Neurosci. 2010 Nov 17;30(46):15337-57. doi: 10.1523/JNEUROSCI.3467-10.2010. J Neurosci. 2010. PMID: 21084591 Free PMC article. Review.
• Matrix metalloproteinase-9 contributes to intestinal tumourigenesis in the adenomatous polyposis coli multiple intestinal neoplasia mouse.
  Sinnamon MJ, Carter KJ, Fingleton B, Matrisian LM. Sinnamon MJ, et al. Int J Exp Pathol. 2008 Dec;89(6):466-75. doi: 10.1111/j.1365-2613.2008.00621.x. Int J Exp Pathol. 2008. PMID: 19134056 Free PMC article.
• High density of tryptase-positive mast cells in human colorectal cancer: a poor prognostic factor related to protease-activated receptor 2 expression.
  Malfettone A, Silvestris N, Saponaro C, Ranieri G, Russo A, Caruso S, Popescu O, Simone G, Paradiso A, Mangia A. Malfettone A, et al. J Cell Mol Med. 2013 Aug;17(8):1025-37. doi: 10.1111/jcmm.12073. J Cell Mol Med. 2013. PMID: 23991686 Free PMC article.
• RNAi-mediated silencing of the Skp-2 gene causes inhibition of growth and induction of apoptosis in human renal carcinoma cells.
  Lu H, Gan M, Cao X, Chen L, Yang Z, Hu W. Lu H, et al. Int J Clin Exp Pathol. 2014 Jun 15;7(7):3845-52. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25120761 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • ORBi (University of Liege)

• Other Literature Sources

  • The Lens - Patent Citations Database